AIMS: There is evidence that altered retinal blood flow and altered retinal blood flow regulation play a role in the development and progression of diabetic retinopathy. We compared the association between systemic blood pressure and retinal white blood cell flux in patients with type 1 diabetes and healthy control subjects. METHODS: The study was performed in 100 patients with type 1 diabetes with no or minimal diabetic retinopathy and a group of 313 age-matched healthy controls. Inclusion criteria were systolic blood pressure ≤ 160 mmHg and diastolic blood pressure ≤ 95 mmHg. None of the subjects took vasoactive medication except insulin. The blue field entoptic technique was used to assess retinal white blood cell flux, velocity and density in the perimacular region. Pressure-flow relationships were calculated for both groups to assess differences in blood flow regulation. RESULTS: Retinal white blood cell flux was comparable between the two study groups. Both type 1 diabetic patients and healthy subjects showed a significant positive correlation between retinal white blood cell flux and mean arterial pressure (diabetic patients: r=0.48; p<0.05, healthy subjects r=0.28). The correlation coefficients between mean arterial pressure and white blood cell flux were significantly higher in patients with diabetes than in the healthy control group (p=0.0459). CONCLUSION: Retinal white blood cell flux, as assessed with the blue-field entoptic technique, is not significantly different between type 1 diabetic patients with no or minimal retinopathy and healthy control subjects. Type 1 diabetic subjects do, however, show an abnormal association between systemic blood pressure and retinal white blood cell flux. This indicates altered autoregulation in early diabetic retinopathy.
AIMS: There is evidence that altered retinal blood flow and altered retinal blood flow regulation play a role in the development and progression of diabetic retinopathy. We compared the association between systemic blood pressure and retinal white blood cell flux in patients with type 1 diabetes and healthy control subjects. METHODS: The study was performed in 100 patients with type 1 diabetes with no or minimal diabetic retinopathy and a group of 313 age-matched healthy controls. Inclusion criteria were systolic blood pressure ≤ 160 mmHg and diastolic blood pressure ≤ 95 mmHg. None of the subjects took vasoactive medication except insulin. The blue field entoptic technique was used to assess retinal white blood cell flux, velocity and density in the perimacular region. Pressure-flow relationships were calculated for both groups to assess differences in blood flow regulation. RESULTS: Retinal white blood cell flux was comparable between the two study groups. Both type 1 diabeticpatients and healthy subjects showed a significant positive correlation between retinal white blood cell flux and mean arterial pressure (diabeticpatients: r=0.48; p<0.05, healthy subjects r=0.28). The correlation coefficients between mean arterial pressure and white blood cell flux were significantly higher in patients with diabetes than in the healthy control group (p=0.0459). CONCLUSION: Retinal white blood cell flux, as assessed with the blue-field entoptic technique, is not significantly different between type 1 diabeticpatients with no or minimal retinopathy and healthy control subjects. Type 1 diabetic subjects do, however, show an abnormal association between systemic blood pressure and retinal white blood cell flux. This indicates altered autoregulation in early diabetic retinopathy.
Authors: G Fuchsjäger-Mayrl; K Polak; A Luksch; E Polska; G T Dorner; G Rainer; H G Eichler; L Schmetterer Journal: Graefes Arch Clin Exp Ophthalmol Date: 2001-09 Impact factor: 3.117
Authors: Kit Guan; Chris Hudson; Tien Wong; Mila Kisilevsky; Ravi K Nrusimhadevara; Wai Ching Lam; Mark Mandelcorn; Robert G Devenyi; John G Flanagan Journal: Diabetes Date: 2006-03 Impact factor: 9.461
Authors: G T Feke; S M Buzney; H Ogasawara; N Fujio; D G Goger; N P Spack; K H Gabbay Journal: Invest Ophthalmol Vis Sci Date: 1994-06 Impact factor: 4.799
Authors: S E Bursell; A C Clermont; B T Kinsley; D C Simonson; L M Aiello; H A Wolpert Journal: Invest Ophthalmol Vis Sci Date: 1996-04 Impact factor: 4.799
Authors: Wineke Bakker; Pieter Sipkema; Coen D A Stehouwer; Erik H Serne; Yvo M Smulders; Victor W M van Hinsbergh; Etto C Eringa Journal: Diabetes Date: 2007-12-17 Impact factor: 9.461